BRIDGEBIO PHARMA
BridgeBio is a biotechnology company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. BridgeBio creates a bridge from advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. BridgeBio's mission is to discover, create, test, and deliver transformative medicines to treat patients with genetic diseases.
BRIDGEBIO PHARMA
Industry:
Biotechnology Health Care Life Science Medical Pharmaceutical
Founded:
2014-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.bridgebio.com
Total Employee:
251+
Status:
Active
Contact:
650-391-9740
Email Addresses:
[email protected]
Total Funding:
1.95 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager WordPress Domain Not Resolving Apache
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-10-05 | Eidos Therapeutics | Eidos Therapeutics acquired by BridgeBio Pharma | 175 M USD |
Investors List
Perceptive Advisors
Perceptive Advisors investment in Series D - BridgeBio Pharma
Sequoia Capital
Sequoia Capital investment in Series D - BridgeBio Pharma
AIG Investments
AIG Investments investment in Series D - BridgeBio Pharma
Cormorant Capital
Cormorant Capital investment in Series D - BridgeBio Pharma
Aisling Capital
Aisling Capital investment in Series D - BridgeBio Pharma
Viking Global Investors
Viking Global Investors investment in Series D - BridgeBio Pharma
Hercules Capital
Hercules Capital investment in Series D - BridgeBio Pharma
Kohlberg Kravis Roberts
Kohlberg Kravis Roberts investment in Series D - BridgeBio Pharma
Janus Fund
Janus Fund investment in Series C - BridgeBio Pharma
Perceptive Advisors
Perceptive Advisors investment in Series C - BridgeBio Pharma
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-04-05 | Eidos Therapeutics | BridgeBio Pharma investment in Series B - Eidos Therapeutics | 64 M USD |
| 2018-01-30 | QED Therapeutics | BridgeBio Pharma investment in Venture Round - QED Therapeutics | 65 M USD |
| 2017-08-01 | PellePharm | BridgeBio Pharma investment in Series B - PellePharm | 20 M USD |
| 2015-04-30 | MyoKardia | BridgeBio Pharma investment in Series B - MyoKardia | 46 M USD |
| 2014-08-22 | MyoKardia | BridgeBio Pharma investment in Venture Round - MyoKardia | 10 M USD |
Official Site Inspections
http://www.bridgebio.com Semrush global rank: 2.1 M Semrush visits lastest month: 9.77 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
